Steen Riisgaard – Biography
Last update: February 16, 2026Executive profile
Steen was President & CEO at Novozymes, and Corporate Executive Vice President, Enzyme Business at Novo Nordisk. Steen Riisgaard joined Xellia Pharma in 2011. Steen served as Vice Chairman of the Board at Xellia Pharma.
Steen Riisgaard is currentlyChairman of the Board at Xellia Pharma - View - Xellia Pharma org chart
Director (until Apr 2026) at Novo Holdings - View - Novo Holdings org chart
Create your alert
to follow the career of Steen Riisgaard.
Education
In 1976, Steen Riisgaard completed a Master of Science in Microbiology at University of Copenhagen.
They have also studied at University of Copenhagen :
- Martin Holst Lange - Novo Nordisk
- Peter Beske Nielsen - EQT
- Benedikte Leroy - DSV Global Transport and Logistics
Find more alumni from University of Copenhagen
More about Steen Riisgaard
Selected links
Do you need to know more about Steen Riisgaard? More results.
Participate
Social media
- Steen Riisgaard on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Steen Riisgaard
The colleagues of Steen Riisgaard
Company Colleagues
- At Xellia Pharma, Steen Riisgaard has 17 colleagues including Michael Kocher (CEO), Henrik Kjær Hansen (Director)…
- At Novo Holdings, Steen Riisgaard has 32 colleagues including Kasim Kutay (CEO), Francis Cuss (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Steen Riisgaard has 22,988 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Steen Riisgaard.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Steen Riisgaard.
